The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma
The proteasome has been validated as an anticancer drug target, while the role of a subunit of proteasome, PSMC6, in lung adenocarcinoma (LUAD) has not been fully unveiled. In this study, we observed that both the RNA and protein of PSMC6 were highly upregulated in LUAD compared with the adjacent no...
Main Authors: | Jian-Yu Zhang, Ke-Zhi Shi, Xiang-Yu Liao, Shi-Jun Li, Dan Bao, Ying Qian, Dao-Jun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/9922185 |
Similar Items
-
Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration
by: Qingke Chen, et al.
Published: (2021-04-01) -
Inhibition of lung adenocarcinoma metastasis by ANKRD52
by: Yen-Fan Lin, et al.
Published: (2017) -
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway
by: Mengdi Yang, et al.
Published: (2020-07-01) -
PSMC5 Promotes Proliferation and Metastasis of Colorectal Cancer by Activating Epithelial–Mesenchymal Transition Signaling and Modulating Immune Infiltrating Cells
by: Zirui He, et al.
Published: (2021-07-01) -
Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma
by: Hao Zhang, et al.
Published: (2020-12-01)